Hutchinson P J, Palmer R M, Moncada S
Wellcome Research Laboratories, Beckenham, Kent, U.K.
Eur J Pharmacol. 1987 Sep 23;141(3):445-51. doi: 10.1016/0014-2999(87)90563-2.
The comparative pharmacology of endothelium-derived relaxing factor (EDRF) and nitric oxide (NO) was studied on isolated strips of rabbit aorta. Both compounds were equally unstable. The relaxations of the bioassay tissues induced by EDRF released by bradykinin (3-100 nM) and by NO (4-134 nM) were indistinguishable. The stability of both compounds was increased to a similar extent by infusions of superoxide dismutase (SOD; 15 U.ml-1) or of cytochrome c (40 microM). The relaxations induced by EDRF and NO were inhibited to similar extents by infusions of Fe2+, hydroquinone and pyrogallol, an effect attenuated by a concomitant infusion of SOD or cytochrome c. The relaxations induced by both compounds were also inhibited by haemoglobin, however, this effect was unaltered by concomitant infusion of SOD. These data indicate that EDRF and NO have identical biological activity, stability and susceptibility to inactivation by superoxide anions and haemoglobin, providing further confirmation that EDRF is NO.
在内皮衍生舒张因子(EDRF)和一氧化氮(NO)的比较药理学研究中,采用兔主动脉离体条进行实验。两种化合物均同样不稳定。由缓激肽(3 - 100 nM)释放的EDRF和NO(4 - 134 nM)诱导的生物测定组织舒张作用难以区分。通过输注超氧化物歧化酶(SOD;15 U.ml-1)或细胞色素c(40 microM),两种化合物的稳定性均提高到相似程度。通过输注Fe2+、对苯二酚和邻苯三酚,EDRF和NO诱导的舒张作用受到相似程度的抑制,同时输注SOD或细胞色素c可减弱这种作用。两种化合物诱导的舒张作用也受到血红蛋白的抑制,然而,同时输注SOD并不会改变这种作用。这些数据表明,EDRF和NO具有相同的生物学活性、稳定性以及对超氧阴离子和血红蛋白失活的敏感性,进一步证实了EDRF就是NO。